He holds a plethora of patents in the field from antidotes to cocaine toxicity to immunoglobulin and plasmatic protein properties.
RANGUEVAUX, FRANCE, July 21, 2017 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to name Renaud Trouve a Lifetime Achiever. An accomplished listee, Renaud Trouve celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are ail taken into account during the selection process.
Backed by more than 35 years of practiced experience in his field, Dr. Trouve holds a plethora of roles in a variety of fields, including associate professor of anesthesiology at the University of Texas, founder and director of Serendi Ltd., administrator of Consultrade SA, founder and science director of Creative Quantum Glass, and founder, chief executive officer and administrator of ERC Swiss SA. Over the years, he held a number of other research, executive and administrative roles for such institutions as the University of Paris, Columbia University, Transonic Systems France, and Serendi International Consulting.
A graduate of the University of Paris, Dr. Trouve holds a Bachelor of Science in biochemistry, a Master of Science in physiology, a Master of Science in human biology, a PhD in toxicology, an MD-PhD in biophysics, and a Doctor of Science in exp. and clin. pharmacology. His professional affiliations include the American Society of Pharmacology and Experimental Therapeutics, the American Heart Association, and the British Pharmacological Society. Throughout his career, he has achieved much; he holds a plethora of patents in the field from antidotes to cocaine toxicity to immunoglobulin and plasmatic protein properties. He developed the use of nanotechnology surface treatment in medical devices and was a pioneer in micro and macro blood flow measurements.
In addition to his influence and accomplishments in his industry, he has lent his expertise to a number of creative works, including "Toxicomanies" and the New England Journal of Medicine. A stellar example of skill in his field, he has won many awards for his work, including but not limited to the many features he has had in Who's Who in Medicine and Healthcare, Who's Who in Science and Engineering, and Who's Who in the World.
In recognition of outstanding contributions to his profession and the Marquis Who's Who community, Renaud Trouve has been featured on the Marquis Who's Who Lifetime Achievers website. Please visit www.ltachievers.com for more information about this honor.
About Marquis Who's Who :
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America , Marquis Who's Who has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis publications may be visited at the official Marquis Who's Who website at www.marquiswhoswho.com.
# # #